GH
Income statement / Annual
Last year (2023), Guardant Health, Inc.'s total revenue was $563.95 M,
an increase of 25.45% from the previous year.
In 2023, Guardant Health, Inc.'s net income was -$479.45 M.
See Guardant Health, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$563.95 M
|
$449.54 M
|
$373.65 M
|
$286.73 M
|
$214.38 M
|
$90.64 M
|
$49.84 M
|
$25.25 M
|
| Cost of Revenue |
$227.05 M |
$156.33 M |
$122.91 M |
$92.54 M |
$70.72 M |
$43.21 M |
$31.62 M |
$22.12 M |
| Gross Profit |
$336.90 M |
$293.21 M |
$250.74 M |
$194.20 M |
$143.66 M |
$47.43 M |
$18.22 M |
$3.13 M |
| Gross Profit Ratio |
0.6 |
0.65 |
0.67 |
0.68 |
0.67 |
0.52 |
0.37 |
0.12 |
| Research and Development
Expenses |
$367.19 M
|
$373.81 M
|
$263.22 M
|
$149.86 M
|
$86.29 M
|
$50.71 M
|
$25.56 M
|
$10.86 M
|
| General & Administrative
Expenses |
$155.80 M
|
$163.96 M
|
$206.64 M
|
$192.77 M
|
$61.40 M
|
$36.19 M
|
$36.78 M
|
$9.92 M
|
| Selling & Marketing
Expenses |
$295.23 M
|
$299.83 M
|
$191.88 M
|
$106.51 M
|
$78.34 M
|
$53.47 M
|
$32.50 M
|
$26.19 M
|
| Selling, General &
Administrative Expenses |
$451.03 M
|
$463.78 M
|
$398.52 M
|
$299.28 M
|
$139.73 M
|
$89.66 M
|
$69.27 M
|
$36.11 M
|
| Other Expenses |
$83.40 M |
-$112.56 M |
$25.18 M |
$3.64 M |
$88,000.00 |
$4.70 M |
-$1.06 M |
-$1,000.00 |
| Operating Expenses |
$901.62 M |
$837.59 M |
$661.74 M |
$449.15 M |
$226.03 M |
$140.37 M |
$94.84 M |
$46.97 M |
| Cost And Expenses |
$1.13 B |
$993.92 M |
$784.65 M |
$541.68 M |
$296.75 M |
$183.58 M |
$126.45 M |
$69.10 M |
| Interest Income |
$35.37 M |
$6.07 M |
$3.93 M |
$10.17 M |
$13.74 M |
$5.27 M |
$2.23 M |
$733,000.00 |
| Interest Expense |
$2.58 M |
$2.58 M |
$2.58 M |
$4.77 M |
$1.18 M |
$1.25 M |
$2.70 M |
$3.02 M |
| Depreciation &
Amortization |
$42.88 M
|
$35.96 M
|
$22.27 M
|
$16.07 M
|
$13.61 M
|
$7.14 M
|
$5.21 M
|
$3.69 M
|
| EBITDA |
-$433.31 M
|
-$614.91 M
|
-$359.62 M
|
-$225.07 M
|
-$54.93 M
|
-$75.84 M
|
-$75.31 M
|
-$39.42 M
|
| EBITDA Ratio |
-0.77 |
-1.45 |
-1.02 |
-0.84 |
-0.32 |
-0.92 |
-1.41 |
-1.56 |
| Operating Income Ratio
|
-1
|
-1.21
|
-1.1
|
-0.89
|
-0.38
|
-1.03
|
-1.54
|
-1.74
|
| Total Other
Income/Expenses Net |
$85.96 M
|
-$109.07 M
|
$26.53 M
|
$9.05 M
|
$12.65 M
|
$8.72 M
|
-$6.60 M
|
-$2.29 M
|
| Income Before Tax |
-$478.76 M |
-$653.45 M |
-$384.47 M |
-$245.90 M |
-$69.72 M |
-$84.23 M |
-$83.21 M |
-$46.13 M |
| Income Before Tax Ratio
|
-0.85
|
-1.45
|
-1.03
|
-0.86
|
-0.33
|
-0.93
|
-1.67
|
-1.83
|
| Income Tax Expense |
$685,000.00 |
$1.14 M |
$300,000.00 |
$379,000.00 |
-$1.87 M |
$38,000.00 |
$7,000.00 |
$6,000.00 |
| Net Income |
-$479.45 M |
-$654.59 M |
-$384.77 M |
-$246.28 M |
-$67.85 M |
-$85.06 M |
-$83.22 M |
-$46.14 M |
| Net Income Ratio |
-0.85 |
-1.46 |
-1.03 |
-0.86 |
-0.32 |
-0.94 |
-1.67 |
-1.83 |
| EPS |
-4.28 |
-6.41 |
-3.8 |
-2.53 |
-0.75 |
-2.8 |
-1.18 |
-0.65 |
| EPS Diluted |
-4.28 |
-6.41 |
-3.8 |
-2.53 |
-0.75 |
-2.8 |
-1.18 |
-0.65 |
| Weighted Average Shares
Out |
$111.99 M
|
$102.18 M
|
$101.31 M
|
$97.50 M
|
$90.60 M
|
$30.40 M
|
$70.72 M
|
$70.72 M
|
| Weighted Average Shares
Out Diluted |
$111.99 M
|
$102.18 M
|
$101.31 M
|
$97.50 M
|
$90.60 M
|
$30.40 M
|
$70.72 M
|
$70.72 M
|
| Link |
|
|
|
|
|
|
|
|
